![Loïc Vincent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 245 363 $ al 31/05/2026
Loïc Vincent currently works at Korro Bio, Inc., as Chief Scientific Officer from 2025.
Dr. Vincent also formerly worked at Affini-T Therapeutics, Inc., as Chief Scientific Officer.
Dr. Vincent received his doctorate degree from Université de Rouen Normandie.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,13 % | 16/06/2026 | 18.297 ( 0,13 % ) | 245 363 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Université de Rouen Normandie
 Université de Rouen Normandie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
